Invention Grant
- Patent Title: Compounds and uses thereof for the modulation of hemoglobin
-
Application No.: US16186275Application Date: 2018-11-09
-
Publication No.: US11053195B2Publication Date: 2021-07-06
- Inventor: Qing Xu , Zhe Li , Stephen L. Gwaltney, II
- Applicant: Global Blood Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Global Blood Therapeutics, Inc.
- Current Assignee: Global Blood Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D207/08
- IPC: C07D207/08 ; C07D265/30 ; C07D401/12 ; C07D211/30 ; C07D403/12 ; C07C271/16 ; C07D207/34 ; C07D207/48 ; C07D211/16 ; C07D211/22 ; C07D211/60 ; C07D211/78 ; C07D213/81 ; C07D241/04 ; C07D279/12 ; C07D309/08 ; C07D309/28 ; C07D333/38 ; C07D335/02 ; C07D401/06 ; C07D403/06
Abstract:
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Public/Granted literature
- US20190202782A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN Public/Granted day:2019-07-04
Information query
